Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 18, Number 2—February 2012


Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010

Michael G. BakerComments to Author , Amanda Kvalsvig, Jane Zhang, Rob Lake, Ann Sears, and Nick Wilson
Author affiliations: University of Otago, Wellington, New Zealand (M.G. Baker, A. Kvalsvig, J. Zhang, A. Sears, N. Wilson); Institute of Environmental Science and Research, Christchurch, New Zealand (R. Lake)

Main Article

Table 1

Incidence of campylobacteriosis and GBS before and after intervention to reduce Campylobacter spp. in poultry, New Zealand 2002–2010*

Incident condition Before intervention, 2002–2006
After intervention, 2008–2010†
Total no. Average/year Rate‡ Total no. Average/year Rate‡ Rate ratio (95% CI) p value
Campylobacteriosis notifications§ 69,207 13,841 339.4 21,217 7,072 163.8 0.48 (0.48–0.49) <0.0001
Campylobacteriosis hospitalizations¶ 4,669 934 23.2 1,603 534 12.2 0.53 (0.51–0.54) <0.0001
GBS hospitalizations¶ 513 103 2.6 290 97 2.2 0.87 (0.81–0.93) 0.0496

*GBS, Guillain-Barré syndrome.
†Excludes 2007, which was a transitional year.
‡Annual no. cases/100,000 person-years at risk. Denominator populations based on mean population estimates published by Statistics New Zealand ( Campylobacteriosis and Guillan-Barré syndrome hospitalizations used age-standardized rates based on the age structure of the New Zealand 2006 Census of Population and Dwellings (
§Published campylobacteriosis notification data (9).
¶Hospitalization data from New Zealand Ministry of Health.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO